Compare

Decoy Therapeutics Inc. vs Lantern Pharma Inc. vs NewcelX Ltd. vs Traws Pharma, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Decoy Therapeutics Inc. DCOY	Lantern Pharma Inc. LTRN	NewcelX Ltd. NCEL	Traws Pharma, Inc. TRAWRevenue covers only part of its income (partial revenue)
Year ended	2025-12-31	2025-12-31	2025-12-31	2025-12-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	-$12.52M	-$17.12M	-$8.30M	$9.17M
EPS (Diluted)	-$129.10	-$1.57	$2.16	$0.82
Operating cash flow	-$4.83M	-$15.68M	-$2.77M	-$18.18M
Free cash flow	-$5.40M	-$15.68M	-$2.77M	-$20.77M
Cash & equivalents	$10.71M	$4.42M	$2.20M	n/a
Total assets	$11.06M	$11.04M	$11.45M	$10.62M
Total liabilities	$5.17M	$4.50M	$4.20M	$11.25M
Shareholders' equity	$5.89M	$6.53M	$7.25M	-$629.0K
Return on year-end equity	-212.6%	-262.0%	-114.5%	n/a
Shares outstanding	n/a	11.25M	4.80M	9.07M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Decoy Therapeutics Inc.	Lantern Pharma Inc.	NewcelX Ltd.	Traws Pharma, Inc.
Latest	$0 Ended 2022-12-31	n/a	n/a	n/a
1 year earlier	$1.84M Ended 2021-12-31	n/a	n/a	n/a
2 years earlier	$5.23M Ended 2020-12-31	n/a	n/a	n/a
3 years earlier	$3.47M Ended 2019-12-31	n/a	n/a	n/a
4 years earlier	$1.95M Ended 2018-12-31	n/a	n/a	n/a